8-Amino-3-benzyl-1,2,4-triazolo[4,3-a]pyrazines. Synthesis and anticonvulsant activity

Area of Science:

• Medicinal Chemistry
• Neuropharmacology
• Organic Synthesis

Background:

• The 1,2,4-triazolo[4,3-a]pyrazine scaffold is explored as a potential bioisostere for purine analogs in anticonvulsant drug discovery.
• Previous research indicates that certain heterocyclic compounds can exhibit significant anticonvulsant properties.

Purpose of the Study:

• To synthesize and evaluate a series of novel substituted 8-amino-3-benzyl-1,2,4-triazolo[4,3-a] pyrazines for anticonvulsant activity.
• To identify lead compounds with potent efficacy against maximal electroshock-induced seizures (MES).

Main Methods:

• Synthesis of eleven substituted 8-amino-3-benzyl-1,2,4-triazolo[4,3-a] pyrazines through a four-stage process starting from phenylacetonitriles.
• Condensation of (2,2,2-triethoxyethyl)benzenes with 2-chloro-3-hydrazinopyrazine to form intermediates.
• Conversion of chloro-triazolopyrazines to the target 8-amine derivatives using methylamine or ammonia.
• Anticonvulsant activity testing in rats using the maximal electroshock-induced seizures (MES) model.

Main Results:

• Several synthesized compounds demonstrated potent anticonvulsant activity against MES.
• Compounds 4 (3-(2-fluorobenzyl)-8-(methylamino)) and 12 (3-(2,6-difluorobenzyl)-8-(methylamino)) exhibited the highest efficacy.
• Compounds 4 and 12 achieved oral ED50 values of 3 mg/kg in the MES model.
• The triazolopyrazine agents showed a reduced tendency to induce emesis compared to other anticonvulsants.

Conclusions:

• The 1,2,4-triazolo[4,3-a]pyrazine ring system is a viable scaffold for developing novel anticonvulsant agents.
• The synthesized 8-amino-3-benzyl-1,2,4-triazolo[4,3-a] pyrazines, particularly fluorinated analogs, represent promising candidates for further investigation in epilepsy treatment.
• These compounds offer a potential therapeutic advantage due to their efficacy and reduced emetic side effects.